Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 7.09163161 |
2 | Golgi transport vesicle coating (GO:0048200) | 7.09163161 |
3 | muscle filament sliding (GO:0030049) | 6.49116425 |
4 | actin-myosin filament sliding (GO:0033275) | 6.49116425 |
5 | protein maturation by protein folding (GO:0022417) | 5.96535956 |
6 | regulation of sequestering of triglyceride (GO:0010889) | 5.63641241 |
7 | actin-mediated cell contraction (GO:0070252) | 5.31712644 |
8 | creatine metabolic process (GO:0006600) | 5.04265220 |
9 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.97275279 |
10 | endocrine pancreas development (GO:0031018) | 4.94190740 |
11 | skeletal muscle contraction (GO:0003009) | 4.87448213 |
12 | regulation of skeletal muscle contraction (GO:0014819) | 4.79239267 |
13 | peptide hormone processing (GO:0016486) | 4.61759272 |
14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.61627726 |
15 | fatty acid homeostasis (GO:0055089) | 4.57793424 |
16 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.57291317 |
17 | myofibril assembly (GO:0030239) | 4.48233832 |
18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.47632360 |
19 | insulin secretion (GO:0030073) | 4.43507383 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.43448753 |
21 | NADH metabolic process (GO:0006734) | 4.31196505 |
22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.27317989 |
23 | detection of calcium ion (GO:0005513) | 4.25155692 |
24 | protein retention in ER lumen (GO:0006621) | 4.09084653 |
25 | striated muscle contraction (GO:0006941) | 4.07885225 |
26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.00591841 |
27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.94808607 |
28 | triglyceride catabolic process (GO:0019433) | 3.93885894 |
29 | COPII vesicle coating (GO:0048208) | 3.93236916 |
30 | nitric oxide mediated signal transduction (GO:0007263) | 3.91339112 |
31 | regulation of insulin secretion (GO:0050796) | 3.89054964 |
32 | regulation of relaxation of muscle (GO:1901077) | 3.88971427 |
33 | fatty acid transmembrane transport (GO:1902001) | 3.86343132 |
34 | glycogen catabolic process (GO:0005980) | 3.84300209 |
35 | synaptic vesicle maturation (GO:0016188) | 3.83759554 |
36 | actin filament-based movement (GO:0030048) | 3.82632802 |
37 | positive regulation of insulin secretion (GO:0032024) | 3.81607669 |
38 | low-density lipoprotein particle clearance (GO:0034383) | 3.80398025 |
39 | response to muscle activity (GO:0014850) | 3.78841371 |
40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77075249 |
41 | glandular epithelial cell differentiation (GO:0002067) | 3.73659696 |
42 | negative regulation of norepinephrine secretion (GO:0010700) | 3.70062615 |
43 | cardiac myofibril assembly (GO:0055003) | 3.66927903 |
44 | sarcomere organization (GO:0045214) | 3.64512754 |
45 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.64462474 |
46 | negative regulation of catecholamine secretion (GO:0033604) | 3.61865707 |
47 | skeletal muscle fiber development (GO:0048741) | 3.61262974 |
48 | acylglycerol catabolic process (GO:0046464) | 3.57326951 |
49 | neutral lipid catabolic process (GO:0046461) | 3.57326951 |
50 | carnitine shuttle (GO:0006853) | 3.55985903 |
51 | vesicle coating (GO:0006901) | 3.55427689 |
52 | glucan catabolic process (GO:0009251) | 3.55368507 |
53 | neuronal action potential propagation (GO:0019227) | 3.53709878 |
54 | regulation of peptide hormone secretion (GO:0090276) | 3.53192794 |
55 | synaptic vesicle exocytosis (GO:0016079) | 3.52143776 |
56 | regulation of peptide secretion (GO:0002791) | 3.49618567 |
57 | regulation of cell communication by electrical coupling (GO:0010649) | 3.47266059 |
58 | type B pancreatic cell development (GO:0003323) | 3.45846285 |
59 | exocrine pancreas development (GO:0031017) | 3.42313319 |
60 | glucan biosynthetic process (GO:0009250) | 3.42215492 |
61 | glycogen biosynthetic process (GO:0005978) | 3.42215492 |
62 | regulation of oxidative phosphorylation (GO:0002082) | 3.40829655 |
63 | cardiac muscle contraction (GO:0060048) | 3.39360050 |
64 | muscle contraction (GO:0006936) | 3.38278856 |
65 | peptide hormone secretion (GO:0030072) | 3.38205991 |
66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37774581 |
67 | myotube cell development (GO:0014904) | 3.36017097 |
68 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.32559541 |
69 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.30837443 |
70 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.30098028 |
71 | negative regulation of insulin secretion (GO:0046676) | 3.29446725 |
72 | peptide secretion (GO:0002790) | 3.26841932 |
73 | regulation of membrane repolarization (GO:0060306) | 3.26704968 |
74 | cellular polysaccharide catabolic process (GO:0044247) | 3.26304164 |
75 | glandular epithelial cell development (GO:0002068) | 3.25023834 |
76 | lipid particle organization (GO:0034389) | 3.24418843 |
77 | regulation of synaptic vesicle transport (GO:1902803) | 3.23199880 |
78 | cellular response to glucagon stimulus (GO:0071377) | 3.20433046 |
79 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.19530259 |
80 | cerebellar Purkinje cell layer development (GO:0021680) | 3.17167452 |
81 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.16209268 |
82 | chemosensory behavior (GO:0007635) | 3.15278724 |
83 | positive regulation of peptide hormone secretion (GO:0090277) | 3.14606195 |
84 | response to inactivity (GO:0014854) | 3.14568117 |
85 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.13536505 |
86 | positive regulation of peptide secretion (GO:0002793) | 3.13179158 |
87 | positive regulation of nuclease activity (GO:0032075) | 3.09208482 |
88 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.09119513 |
89 | signal peptide processing (GO:0006465) | 3.08795483 |
90 | glycerolipid catabolic process (GO:0046503) | 3.08036369 |
91 | regulation of hormone secretion (GO:0046883) | 3.07432954 |
92 | brown fat cell differentiation (GO:0050873) | 3.06612566 |
93 | glutamate secretion (GO:0014047) | 3.06541592 |
94 | activation of protein kinase A activity (GO:0034199) | 3.04552305 |
95 | locomotory exploration behavior (GO:0035641) | 3.03159838 |
96 | oxaloacetate metabolic process (GO:0006107) | 3.02666156 |
97 | ER overload response (GO:0006983) | 3.00200828 |
98 | cell communication by electrical coupling (GO:0010644) | 2.99124547 |
99 | muscle system process (GO:0003012) | 2.98370268 |
100 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.98365995 |
101 | plasma membrane repair (GO:0001778) | 2.97009421 |
102 | polysaccharide catabolic process (GO:0000272) | 2.93590092 |
103 | negative regulation of peptide hormone secretion (GO:0090278) | 2.93201604 |
104 | membrane repolarization during action potential (GO:0086011) | 2.92874981 |
105 | diacylglycerol metabolic process (GO:0046339) | 2.90368769 |
106 | actomyosin structure organization (GO:0031032) | 2.89931204 |
107 | muscle fiber development (GO:0048747) | 2.89590433 |
108 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.88784687 |
109 | positive regulation of glycolytic process (GO:0045821) | 2.88098760 |
110 | regulation of norepinephrine secretion (GO:0014061) | 2.87638958 |
111 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87610750 |
112 | gluconeogenesis (GO:0006094) | 2.87077231 |
113 | positive regulation of exocytosis (GO:0045921) | 2.86827906 |
114 | regulation of actin filament-based movement (GO:1903115) | 2.86268364 |
115 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.85695395 |
116 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.84261957 |
117 | sequestering of metal ion (GO:0051238) | 2.84213532 |
118 | succinate metabolic process (GO:0006105) | 2.80869542 |
119 | negative regulation of peptide secretion (GO:0002792) | 2.80776335 |
120 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.80378218 |
121 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.80270032 |
122 | regulation of peptide transport (GO:0090087) | 2.79896150 |
123 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.76232109 |
124 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75769085 |
125 | regulation of nuclease activity (GO:0032069) | 2.75425802 |
126 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75417125 |
127 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.73524312 |
128 | positive regulation of lipid storage (GO:0010884) | 2.73273083 |
129 | protein localization to Golgi apparatus (GO:0034067) | 2.72534202 |
130 | toxin metabolic process (GO:0009404) | 2.72345255 |
131 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.70282159 |
132 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.70282159 |
133 | transcytosis (GO:0045056) | 2.69587341 |
134 | response to dietary excess (GO:0002021) | 2.67437523 |
135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66655231 |
136 | response to epinephrine (GO:0071871) | 2.66147264 |
137 | fatty acid beta-oxidation (GO:0006635) | 2.63992719 |
138 | cardiac muscle hypertrophy (GO:0003300) | 2.63224575 |
139 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.62828763 |
140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.62828763 |
141 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.62690545 |
142 | cellular zinc ion homeostasis (GO:0006882) | 2.62507744 |
143 | regulation of glucocorticoid secretion (GO:2000849) | 2.61276638 |
144 | neurotransmitter secretion (GO:0007269) | 2.59971572 |
145 | tricarboxylic acid metabolic process (GO:0072350) | 2.59852978 |
146 | signal release (GO:0023061) | 2.59575901 |
147 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.59150964 |
148 | cellular response to unfolded protein (GO:0034620) | 2.58278722 |
149 | hormone secretion (GO:0046879) | 2.57731039 |
150 | activation of adenylate cyclase activity (GO:0007190) | 2.57634069 |
151 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.57570317 |
152 | cellular response to topologically incorrect protein (GO:0035967) | 2.57396622 |
153 | regulation of vesicle fusion (GO:0031338) | 2.57352417 |
154 | neuromuscular synaptic transmission (GO:0007274) | 2.57094372 |
155 | inner ear receptor cell development (GO:0060119) | 2.56923823 |
156 | striated muscle hypertrophy (GO:0014897) | 2.56601090 |
157 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.56590295 |
158 | alanine transport (GO:0032328) | 2.56187144 |
159 | negative regulation of appetite (GO:0032099) | 2.56159688 |
160 | negative regulation of response to food (GO:0032096) | 2.56159688 |
161 | cellular response to epinephrine stimulus (GO:0071872) | 2.55594877 |
162 | ethanol oxidation (GO:0006069) | 2.54455347 |
163 | regulation of autophagic vacuole assembly (GO:2000785) | 2.54318836 |
164 | innervation (GO:0060384) | 2.53885525 |
165 | carnitine transmembrane transport (GO:1902603) | 2.53826819 |
166 | lipid storage (GO:0019915) | 2.53720271 |
167 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.53141343 |
168 | adult heart development (GO:0007512) | 2.53049260 |
169 | peptide transport (GO:0015833) | 2.52954562 |
170 | hexose biosynthetic process (GO:0019319) | 2.52739375 |
171 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.52638326 |
172 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.51450791 |
173 | regulation of hexokinase activity (GO:1903299) | 2.51437779 |
174 | regulation of glucokinase activity (GO:0033131) | 2.51437779 |
175 | fructose metabolic process (GO:0006000) | 2.51229142 |
176 | ER-nucleus signaling pathway (GO:0006984) | 2.51083250 |
177 | response to glucagon (GO:0033762) | 2.51074402 |
178 | white fat cell differentiation (GO:0050872) | 2.50090696 |
179 | regulation of exocytosis (GO:0017157) | 2.49382775 |
180 | regulation of lipoprotein metabolic process (GO:0050746) | 2.49159858 |
181 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.49021461 |
182 | positive regulation of membrane potential (GO:0045838) | 2.48835628 |
183 | lactate metabolic process (GO:0006089) | 2.48716384 |
184 | skeletal muscle tissue development (GO:0007519) | 2.48308854 |
185 | positive regulation of hormone secretion (GO:0046887) | 2.47703930 |
186 | fatty acid catabolic process (GO:0009062) | 2.46703625 |
187 | response to hexose (GO:0009746) | 2.46166773 |
188 | amino-acid betaine transport (GO:0015838) | 2.45086451 |
189 | carnitine transport (GO:0015879) | 2.45086451 |
190 | * glycogen metabolic process (GO:0005977) | 2.44929933 |
191 | response to glucose (GO:0009749) | 2.44905496 |
192 | response to catecholamine (GO:0071869) | 2.41901516 |
193 | response to monoamine (GO:0071867) | 2.41901516 |
194 | positive regulation of fatty acid oxidation (GO:0046321) | 2.39064120 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.87578387 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.52078046 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.24767110 |
4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.89233489 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80041064 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.57684438 |
7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44638360 |
8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44226769 |
9 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.43823155 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.33052483 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32881673 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22896682 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20214370 |
14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20017626 |
15 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12121751 |
16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10596485 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.07488128 |
18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04964095 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02330475 |
20 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.98975893 |
21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93433210 |
22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92544678 |
23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92544678 |
24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.88302160 |
25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.85294805 |
26 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82427414 |
27 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.81538181 |
28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81107714 |
29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80571992 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76896743 |
31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76844831 |
32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69968651 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67701430 |
34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.64319125 |
35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.62977989 |
36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60028513 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54530786 |
38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53816184 |
39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53663000 |
40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53058477 |
41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49945374 |
42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48178728 |
43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.44311254 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44194437 |
45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41288535 |
46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40528215 |
47 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.40447261 |
48 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38619160 |
49 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38576828 |
50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37798717 |
51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37456162 |
52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36723534 |
53 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33760286 |
54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32002660 |
55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31725107 |
56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29494620 |
57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29387100 |
58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26385064 |
59 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24455129 |
60 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24455129 |
61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22039421 |
62 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.21718430 |
63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.18566224 |
64 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17922521 |
65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14459246 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13937668 |
67 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.13671787 |
68 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12983771 |
69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12060799 |
70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10365652 |
71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08850624 |
72 | AR_19668381_ChIP-Seq_PC3_Human | 1.08231783 |
73 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08161585 |
74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07312271 |
75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06392683 |
76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06189103 |
77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05864274 |
78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05169508 |
79 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.04743875 |
80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04722556 |
81 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04197371 |
82 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02962007 |
83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02354648 |
84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01086426 |
85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00535802 |
86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00151199 |
87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98676140 |
88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98423336 |
89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98080180 |
90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97182827 |
91 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96309766 |
92 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95900058 |
93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95429538 |
94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95140167 |
95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94762201 |
96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.93694731 |
97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93514192 |
98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92661433 |
99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92635656 |
100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92136216 |
101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91629397 |
102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91132402 |
103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90706494 |
104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90304220 |
105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89584873 |
106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88973567 |
107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88788376 |
108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88662986 |
109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88351986 |
110 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87310411 |
111 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.87276714 |
112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86246844 |
113 | P300_19829295_ChIP-Seq_ESCs_Human | 0.85852608 |
114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84369663 |
115 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83585063 |
116 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82747394 |
117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82615348 |
118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82090888 |
119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81515151 |
120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81454103 |
121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.81431846 |
122 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81165643 |
123 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81122032 |
124 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80906705 |
125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80664683 |
126 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80647505 |
127 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80552618 |
128 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80471195 |
129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80304935 |
130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.80228720 |
131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78566160 |
132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78310732 |
133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77959232 |
134 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77865872 |
135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77787808 |
136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77324075 |
137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77233142 |
138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76721437 |
139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76457252 |
140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75490780 |
141 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75140210 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 4.99586174 |
2 | MP0003283_abnormal_digestive_organ | 4.71566032 |
3 | MP0003646_muscle_fatigue | 4.40239102 |
4 | MP0004130_abnormal_muscle_cell | 4.25158952 |
5 | MP0005670_abnormal_white_adipose | 3.90784645 |
6 | MP0000751_myopathy | 3.85931022 |
7 | MP0009780_abnormal_chondrocyte_physiolo | 3.73620268 |
8 | MP0002909_abnormal_adrenal_gland | 3.60488752 |
9 | MP0000749_muscle_degeneration | 3.23755267 |
10 | MP0004859_abnormal_synaptic_plasticity | 3.17308049 |
11 | MP0003195_calcinosis | 3.02655493 |
12 | MP0002877_abnormal_melanocyte_morpholog | 2.98938378 |
13 | MP0002693_abnormal_pancreas_physiology | 2.98353613 |
14 | MP0000013_abnormal_adipose_tissue | 2.90678931 |
15 | MP0010386_abnormal_urinary_bladder | 2.87723269 |
16 | MP0004270_analgesia | 2.76680111 |
17 | MP0004036_abnormal_muscle_relaxation | 2.70772067 |
18 | MP0001944_abnormal_pancreas_morphology | 2.70421477 |
19 | MP0005666_abnormal_adipose_tissue | 2.70228858 |
20 | MP0002971_abnormal_brown_adipose | 2.58072977 |
21 | MP0002837_dystrophic_cardiac_calcinosis | 2.49479678 |
22 | MP0002106_abnormal_muscle_physiology | 2.32893790 |
23 | MP0005646_abnormal_pituitary_gland | 2.27560957 |
24 | MP0004087_abnormal_muscle_fiber | 2.22478234 |
25 | MP0000678_abnormal_parathyroid_gland | 2.22214924 |
26 | MP0000759_abnormal_skeletal_muscle | 2.20006797 |
27 | MP0005379_endocrine/exocrine_gland_phen | 2.19885501 |
28 | * MP0003635_abnormal_synaptic_transmissio | 2.11483724 |
29 | MP0005369_muscle_phenotype | 2.06806932 |
30 | MP0005620_abnormal_muscle_contractility | 2.01969955 |
31 | MP0000747_muscle_weakness | 1.98569322 |
32 | MP0004084_abnormal_cardiac_muscle | 1.98151942 |
33 | MP0004185_abnormal_adipocyte_glucose | 1.98066668 |
34 | MP0002078_abnormal_glucose_homeostasis | 1.85783399 |
35 | MP0001765_abnormal_ion_homeostasis | 1.83540472 |
36 | MP0008961_abnormal_basal_metabolism | 1.79906291 |
37 | MP0006072_abnormal_retinal_apoptosis | 1.78160053 |
38 | MP0002638_abnormal_pupillary_reflex | 1.77485606 |
39 | MP0002734_abnormal_mechanical_nocicepti | 1.76133950 |
40 | MP0003183_abnormal_peptide_metabolism | 1.75905534 |
41 | MP0004215_abnormal_myocardial_fiber | 1.75268158 |
42 | MP0002332_abnormal_exercise_endurance | 1.74606910 |
43 | MP0002063_abnormal_learning/memory/cond | 1.70488123 |
44 | MP0005220_abnormal_exocrine_pancreas | 1.68187339 |
45 | MP0003011_delayed_dark_adaptation | 1.64238553 |
46 | MP0001984_abnormal_olfaction | 1.62893198 |
47 | MP0002972_abnormal_cardiac_muscle | 1.62605021 |
48 | MP0000750_abnormal_muscle_regeneration | 1.62452112 |
49 | MP0002733_abnormal_thermal_nociception | 1.60276659 |
50 | MP0005645_abnormal_hypothalamus_physiol | 1.59724414 |
51 | MP0003122_maternal_imprinting | 1.57856006 |
52 | MP0002269_muscular_atrophy | 1.55441517 |
53 | MP0005330_cardiomyopathy | 1.55160943 |
54 | MP0003880_abnormal_central_pattern | 1.54782574 |
55 | MP0002572_abnormal_emotion/affect_behav | 1.49800245 |
56 | MP0006138_congestive_heart_failure | 1.49788778 |
57 | MP0002234_abnormal_pharynx_morphology | 1.48932036 |
58 | MP0010329_abnormal_lipoprotein_level | 1.48331922 |
59 | MP0009745_abnormal_behavioral_response | 1.47071855 |
60 | MP0005535_abnormal_body_temperature | 1.46708604 |
61 | MP0001756_abnormal_urination | 1.44553492 |
62 | MP0002272_abnormal_nervous_system | 1.44520739 |
63 | MP0002064_seizures | 1.44183739 |
64 | MP0002108_abnormal_muscle_morphology | 1.41804204 |
65 | MP0000003_abnormal_adipose_tissue | 1.40274520 |
66 | MP0001970_abnormal_pain_threshold | 1.36639364 |
67 | MP0002928_abnormal_bile_duct | 1.35210104 |
68 | MP0003123_paternal_imprinting | 1.34429079 |
69 | MP0002735_abnormal_chemical_nociception | 1.32664743 |
70 | MP0001986_abnormal_taste_sensitivity | 1.32640912 |
71 | MP0005385_cardiovascular_system_phenoty | 1.31344718 |
72 | MP0001544_abnormal_cardiovascular_syste | 1.31344718 |
73 | MP0003329_amyloid_beta_deposits | 1.29214231 |
74 | MP0000462_abnormal_digestive_system | 1.29046114 |
75 | MP0001968_abnormal_touch/_nociception | 1.28447906 |
76 | MP0001502_abnormal_circadian_rhythm | 1.27736216 |
77 | MP0004145_abnormal_muscle_electrophysio | 1.27325706 |
78 | MP0002876_abnormal_thyroid_physiology | 1.25174254 |
79 | MP0003953_abnormal_hormone_level | 1.23113334 |
80 | MP0009643_abnormal_urine_homeostasis | 1.22767238 |
81 | MP0004885_abnormal_endolymph | 1.22110952 |
82 | MP0000631_abnormal_neuroendocrine_gland | 1.22015496 |
83 | MP0009115_abnormal_fat_cell | 1.21570901 |
84 | MP0003879_abnormal_hair_cell | 1.21155397 |
85 | MP0005334_abnormal_fat_pad | 1.20919256 |
86 | MP0002822_catalepsy | 1.18863206 |
87 | MP0003137_abnormal_impulse_conducting | 1.17612988 |
88 | MP0004858_abnormal_nervous_system | 1.16774483 |
89 | MP0001501_abnormal_sleep_pattern | 1.13681034 |
90 | MP0000955_abnormal_spinal_cord | 1.12870503 |
91 | MP0002118_abnormal_lipid_homeostasis | 1.11096098 |
92 | MP0006276_abnormal_autonomic_nervous | 1.10916952 |
93 | MP0002557_abnormal_social/conspecific_i | 1.10536182 |
94 | MP0004484_altered_response_of | 1.09973113 |
95 | MP0005266_abnormal_metabolism | 1.09638976 |
96 | MP0005636_abnormal_mineral_homeostasis | 1.07591080 |
97 | MP0008775_abnormal_heart_ventricle | 1.07376736 |
98 | MP0005452_abnormal_adipose_tissue | 1.06635353 |
99 | MP0003172_abnormal_lysosome_physiology | 1.05403480 |
100 | MP0001486_abnormal_startle_reflex | 1.05361389 |
101 | MP0002067_abnormal_sensory_capabilities | 1.04496604 |
102 | MP0002896_abnormal_bone_mineralization | 1.01372037 |
103 | MP0003119_abnormal_digestive_system | 0.98964247 |
104 | MP0004811_abnormal_neuron_physiology | 0.97766092 |
105 | MP0000230_abnormal_systemic_arterial | 0.97099570 |
106 | MP0005451_abnormal_body_composition | 0.96908299 |
107 | MP0005332_abnormal_amino_acid | 0.96404693 |
108 | MP0002069_abnormal_eating/drinking_beha | 0.96338264 |
109 | MP0002736_abnormal_nociception_after | 0.95839652 |
110 | MP0001661_extended_life_span | 0.93451135 |
111 | MP0002184_abnormal_innervation | 0.93252157 |
112 | MP0002970_abnormal_white_adipose | 0.92303519 |
113 | MP0004142_abnormal_muscle_tone | 0.90481670 |
114 | MP0010630_abnormal_cardiac_muscle | 0.90116562 |
115 | MP0005423_abnormal_somatic_nervous | 0.88449523 |
116 | MP0000733_abnormal_muscle_development | 0.88406564 |
117 | MP0003959_abnormal_lean_body | 0.87146608 |
118 | MP0003690_abnormal_glial_cell | 0.86267857 |
119 | MP0009046_muscle_twitch | 0.86157895 |
120 | MP0003787_abnormal_imprinting | 0.85630158 |
121 | MP0005187_abnormal_penis_morphology | 0.85626475 |
122 | MP0002066_abnormal_motor_capabilities/c | 0.84647731 |
123 | MP0000538_abnormal_urinary_bladder | 0.84399366 |
124 | MP0002127_abnormal_cardiovascular_syste | 0.83885675 |
125 | MP0002882_abnormal_neuron_morphology | 0.83644806 |
126 | MP0004233_abnormal_muscle_weight | 0.82887666 |
127 | MP0002653_abnormal_ependyma_morphology | 0.82300410 |
128 | MP0008569_lethality_at_weaning | 0.81337450 |
129 | MP0004510_myositis | 0.80981463 |
130 | MP0002229_neurodegeneration | 0.78013682 |
131 | MP0001270_distended_abdomen | 0.77789875 |
132 | MP0001440_abnormal_grooming_behavior | 0.77392322 |
133 | MP0004264_abnormal_extraembryonic_tissu | 0.76953011 |
134 | MP0004924_abnormal_behavior | 0.76099350 |
135 | MP0005386_behavior/neurological_phenoty | 0.76099350 |
136 | MP0005448_abnormal_energy_balance | 0.74265717 |
137 | MP0005058_abnormal_lysosome_morphology | 0.73485003 |
138 | MP0003633_abnormal_nervous_system | 0.73232672 |
139 | MP0003948_abnormal_gas_homeostasis | 0.73093616 |
140 | MP0006036_abnormal_mitochondrial_physio | 0.72663651 |
141 | MP0005253_abnormal_eye_physiology | 0.72350172 |
142 | MP0005167_abnormal_blood-brain_barrier | 0.72236758 |
143 | MP0001299_abnormal_eye_distance/ | 0.71946050 |
144 | MP0003121_genomic_imprinting | 0.69891715 |
145 | MP0004085_abnormal_heartbeat | 0.69331465 |
146 | MP0002163_abnormal_gland_morphology | 0.69249421 |
147 | MP0001664_abnormal_digestion | 0.68990510 |
148 | MP0003634_abnormal_glial_cell | 0.68180726 |
149 | MP0001485_abnormal_pinna_reflex | 0.66308172 |
150 | MP0005375_adipose_tissue_phenotype | 0.65971495 |
151 | MP0003828_pulmonary_edema | 0.65269014 |
152 | MP0002139_abnormal_hepatobiliary_system | 0.64513185 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 8.22553719 |
2 | Nemaline bodies (HP:0003798) | 8.02030473 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.88090753 |
4 | Exercise-induced myalgia (HP:0003738) | 6.69671835 |
5 | Type 1 muscle fiber predominance (HP:0003803) | 6.42047643 |
6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.15649033 |
7 | Hypoglycemic seizures (HP:0002173) | 5.56097153 |
8 | Exercise-induced muscle cramps (HP:0003710) | 5.51486905 |
9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.28984833 |
10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.23394646 |
11 | Symptomatic seizures (HP:0011145) | 5.08205399 |
12 | Hypokalemic alkalosis (HP:0001949) | 4.93115705 |
13 | Hyperactive renin-angiotensin system (HP:0000841) | 4.88883838 |
14 | Hypoglycemic coma (HP:0001325) | 4.78535452 |
15 | Calf muscle hypertrophy (HP:0008981) | 4.78289098 |
16 | Increased circulating renin level (HP:0000848) | 4.53665509 |
17 | Rhabdomyolysis (HP:0003201) | 4.46528764 |
18 | EMG: myopathic abnormalities (HP:0003458) | 4.35465408 |
19 | Muscle fiber splitting (HP:0003555) | 4.29594226 |
20 | Hypokalemia (HP:0002900) | 4.25987854 |
21 | Hyporeflexia of lower limbs (HP:0002600) | 4.25732073 |
22 | Decreased circulating renin level (HP:0003351) | 4.22185439 |
23 | Ketoacidosis (HP:0001993) | 4.21329775 |
24 | Metabolic alkalosis (HP:0200114) | 4.20985772 |
25 | Distal arthrogryposis (HP:0005684) | 4.19988350 |
26 | Difficulty running (HP:0009046) | 4.13881979 |
27 | Myopathic facies (HP:0002058) | 4.11683094 |
28 | Abnormality of chloride homeostasis (HP:0011422) | 4.08866937 |
29 | Rimmed vacuoles (HP:0003805) | 4.00147278 |
30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.98424610 |
31 | Abnormality of renin-angiotensin system (HP:0000847) | 3.94293275 |
32 | Abnormality of the calf musculature (HP:0001430) | 3.91568209 |
33 | Visual hallucinations (HP:0002367) | 3.79691283 |
34 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.74555806 |
35 | Round ear (HP:0100830) | 3.70989388 |
36 | Frequent falls (HP:0002359) | 3.67667087 |
37 | Hyperaldosteronism (HP:0000859) | 3.66718731 |
38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.63502348 |
39 | Hypomagnesemia (HP:0002917) | 3.56729089 |
40 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.55114217 |
41 | Myotonia (HP:0002486) | 3.52467220 |
42 | Neck muscle weakness (HP:0000467) | 3.50536221 |
43 | Gout (HP:0001997) | 3.49569680 |
44 | Polyuria (HP:0000103) | 3.49198232 |
45 | Abnormality of magnesium homeostasis (HP:0004921) | 3.47124444 |
46 | Abnormality of potassium homeostasis (HP:0011042) | 3.43931434 |
47 | Abnormal pancreas size (HP:0012094) | 3.42394743 |
48 | Sudden death (HP:0001699) | 3.34220731 |
49 | Subaortic stenosis (HP:0001682) | 3.32426465 |
50 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.32426465 |
51 | Late onset (HP:0003584) | 3.29177975 |
52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.29000844 |
53 | Asymmetric septal hypertrophy (HP:0001670) | 3.25152848 |
54 | Bundle branch block (HP:0011710) | 3.25127030 |
55 | Renal salt wasting (HP:0000127) | 3.24579132 |
56 | Muscle stiffness (HP:0003552) | 3.23195924 |
57 | Abnormal urine output (HP:0012590) | 3.19895264 |
58 | Hyperglycemia (HP:0003074) | 3.19198892 |
59 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.15821948 |
60 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.15821948 |
61 | Ulnar deviation of the wrist (HP:0003049) | 3.13859442 |
62 | Large for gestational age (HP:0001520) | 3.13254405 |
63 | Polydipsia (HP:0001959) | 3.09525046 |
64 | Abnormal drinking behavior (HP:0030082) | 3.09525046 |
65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.95388965 |
66 | Pheochromocytoma (HP:0002666) | 2.89269833 |
67 | Adrenal overactivity (HP:0002717) | 2.83175101 |
68 | Generalized aminoaciduria (HP:0002909) | 2.82992862 |
69 | EMG: neuropathic changes (HP:0003445) | 2.82061841 |
70 | Alkalosis (HP:0001948) | 2.80604325 |
71 | Calcaneovalgus deformity (HP:0001848) | 2.76516614 |
72 | Abnormality of renal excretion (HP:0011036) | 2.73834615 |
73 | Fetal akinesia sequence (HP:0001989) | 2.71421274 |
74 | Agitation (HP:0000713) | 2.70335531 |
75 | Hyperkalemia (HP:0002153) | 2.69157498 |
76 | Tetany (HP:0001281) | 2.62611092 |
77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62016188 |
78 | Mucopolysacchariduria (HP:0008155) | 2.62016188 |
79 | Increased connective tissue (HP:0009025) | 2.60552437 |
80 | Generalized muscle weakness (HP:0003324) | 2.55062344 |
81 | Dysostosis multiplex (HP:0000943) | 2.54187306 |
82 | Absent phalangeal crease (HP:0006109) | 2.54018148 |
83 | EEG with generalized epileptiform discharges (HP:0011198) | 2.50864928 |
84 | Epileptiform EEG discharges (HP:0011182) | 2.47125470 |
85 | Neuroendocrine neoplasm (HP:0100634) | 2.46847176 |
86 | Ketosis (HP:0001946) | 2.46383355 |
87 | Hyperparathyroidism (HP:0000843) | 2.45823680 |
88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42988294 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42988294 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42988294 |
91 | Hypsarrhythmia (HP:0002521) | 2.42765439 |
92 | Deformed tarsal bones (HP:0008119) | 2.42756248 |
93 | Distal lower limb muscle weakness (HP:0009053) | 2.40419417 |
94 | Dilated cardiomyopathy (HP:0001644) | 2.40182928 |
95 | Osteomalacia (HP:0002749) | 2.39006344 |
96 | Focal motor seizures (HP:0011153) | 2.38938182 |
97 | Heart block (HP:0012722) | 2.35171399 |
98 | Hypotension (HP:0002615) | 2.35163285 |
99 | Gowers sign (HP:0003391) | 2.30730907 |
100 | Myokymia (HP:0002411) | 2.28828414 |
101 | Increased muscle lipid content (HP:0009058) | 2.26770144 |
102 | Scapular winging (HP:0003691) | 2.25813171 |
103 | Chronic bronchitis (HP:0004469) | 2.23806569 |
104 | Areflexia of lower limbs (HP:0002522) | 2.21680556 |
105 | Lipoatrophy (HP:0100578) | 2.21486978 |
106 | Ventricular tachycardia (HP:0004756) | 2.18531797 |
107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17724875 |
108 | Insulin resistance (HP:0000855) | 2.16201140 |
109 | Anxiety (HP:0000739) | 2.16184706 |
110 | Abnormal atrioventricular conduction (HP:0005150) | 2.13047931 |
111 | Papilledema (HP:0001085) | 2.11419799 |
112 | Hyperphosphaturia (HP:0003109) | 2.11396458 |
113 | Bulbar palsy (HP:0001283) | 2.10713829 |
114 | Abnormality of sodium homeostasis (HP:0010931) | 2.09973641 |
115 | Myoglobinuria (HP:0002913) | 2.08054077 |
116 | Malignant hyperthermia (HP:0002047) | 2.05992420 |
117 | Prolonged QT interval (HP:0001657) | 2.05160638 |
118 | Limb hypertonia (HP:0002509) | 2.02638089 |
119 | Polyphagia (HP:0002591) | 2.01288001 |
120 | Abnormal finger flexion creases (HP:0006143) | 1.99787660 |
121 | Hypercortisolism (HP:0001578) | 1.99631472 |
122 | Weak cry (HP:0001612) | 1.98623985 |
123 | Hyponatremia (HP:0002902) | 1.98554142 |
124 | Depression (HP:0000716) | 1.98077542 |
125 | Atonic seizures (HP:0010819) | 1.97626841 |
126 | Resting tremor (HP:0002322) | 1.97392811 |
127 | Abnormality of purine metabolism (HP:0004352) | 1.96114577 |
128 | Spinal rigidity (HP:0003306) | 1.95862867 |
129 | Exercise intolerance (HP:0003546) | 1.95326160 |
130 | Unilateral renal agenesis (HP:0000122) | 1.93808883 |
131 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91890644 |
132 | Abnormality of the foot musculature (HP:0001436) | 1.90331656 |
133 | Dysautonomia (HP:0002459) | 1.90229481 |
134 | Hyperuricemia (HP:0002149) | 1.89286891 |
135 | Increased purine levels (HP:0004368) | 1.89286891 |
136 | Epileptic encephalopathy (HP:0200134) | 1.88544770 |
137 | Hip contracture (HP:0003273) | 1.86446920 |
138 | Waddling gait (HP:0002515) | 1.85911418 |
139 | Ventricular arrhythmia (HP:0004308) | 1.85668634 |
140 | Absence seizures (HP:0002121) | 1.84572631 |
141 | Abnormal EKG (HP:0003115) | 1.84376250 |
142 | Menstrual irregularities (HP:0000858) | 1.83766385 |
143 | Acanthosis nigricans (HP:0000956) | 1.83323278 |
144 | Hypothermia (HP:0002045) | 1.82954939 |
145 | Generalized tonic-clonic seizures (HP:0002069) | 1.82767813 |
146 | Slender build (HP:0001533) | 1.82327006 |
147 | Abnormal eating behavior (HP:0100738) | 1.81725650 |
148 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79940496 |
149 | Fatigable weakness (HP:0003473) | 1.79940496 |
150 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78372050 |
151 | Foot dorsiflexor weakness (HP:0009027) | 1.77819857 |
152 | Acute necrotizing encephalopathy (HP:0006965) | 1.77367104 |
153 | Atrial fibrillation (HP:0005110) | 1.77204303 |
154 | Syncope (HP:0001279) | 1.77138180 |
155 | Hypophosphatemia (HP:0002148) | 1.76829327 |
156 | Hepatic necrosis (HP:0002605) | 1.76633968 |
157 | Double outlet right ventricle (HP:0001719) | 1.76320861 |
158 | Congenital malformation of the right heart (HP:0011723) | 1.76320861 |
159 | Ventricular fibrillation (HP:0001663) | 1.75328215 |
160 | Restlessness (HP:0000711) | 1.74202240 |
161 | Focal seizures (HP:0007359) | 1.73492977 |
162 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.72415695 |
163 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72049638 |
164 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71678799 |
165 | Abnormal urine phosphate concentration (HP:0012599) | 1.71486446 |
166 | Supranuclear gaze palsy (HP:0000605) | 1.71092429 |
167 | Retinal atrophy (HP:0001105) | 1.70606485 |
168 | Type II lissencephaly (HP:0007260) | 1.70265602 |
169 | Oligomenorrhea (HP:0000876) | 1.68410470 |
170 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68115685 |
171 | Primary atrial arrhythmia (HP:0001692) | 1.67814236 |
172 | Difficulty climbing stairs (HP:0003551) | 1.67251982 |
173 | Distal lower limb amyotrophy (HP:0008944) | 1.66926638 |
174 | Proximal amyotrophy (HP:0007126) | 1.65917427 |
175 | Hyperphosphatemia (HP:0002905) | 1.65579278 |
176 | Limb-girdle muscle atrophy (HP:0003797) | 1.65186858 |
177 | Progressive macrocephaly (HP:0004481) | 1.65039947 |
178 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62940743 |
179 | Thoracolumbar scoliosis (HP:0002944) | 1.62883735 |
180 | Hypercalciuria (HP:0002150) | 1.61986480 |
181 | Glycosuria (HP:0003076) | 1.61572052 |
182 | Abnormality of urine glucose concentration (HP:0011016) | 1.61572052 |
183 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.60636628 |
184 | Cortical visual impairment (HP:0100704) | 1.60314779 |
185 | Irritability (HP:0000737) | 1.60164804 |
186 | Hepatoblastoma (HP:0002884) | 1.57414753 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 5.56646418 |
2 | PASK | 4.81925953 |
3 | TTN | 3.94212594 |
4 | WNK3 | 3.87007430 |
5 | PRKD3 | 3.55150046 |
6 | NTRK3 | 3.49694767 |
7 | MAPK15 | 3.44460500 |
8 | WNK4 | 3.37105129 |
9 | MAP3K2 | 2.70233269 |
10 | NTRK1 | 2.45154238 |
11 | HIPK2 | 2.31201493 |
12 | EPHA4 | 2.04333552 |
13 | MAPK12 | 1.75275810 |
14 | MARK1 | 1.74474427 |
15 | OXSR1 | 1.70607610 |
16 | MAP3K9 | 1.64327132 |
17 | UHMK1 | 1.52428664 |
18 | KSR2 | 1.52072674 |
19 | CAMKK2 | 1.46718966 |
20 | PRKAA2 | 1.44350066 |
21 | PIK3CG | 1.43207593 |
22 | CAMK1 | 1.42447126 |
23 | DAPK2 | 1.38476186 |
24 | MAP3K4 | 1.36008603 |
25 | MINK1 | 1.36006545 |
26 | PHKG1 | 1.32804026 |
27 | PHKG2 | 1.32804026 |
28 | MAP3K1 | 1.31911074 |
29 | PAK3 | 1.31075353 |
30 | CASK | 1.26469236 |
31 | SCYL2 | 1.21549637 |
32 | MUSK | 1.21182664 |
33 | FRK | 1.20444785 |
34 | BCKDK | 1.20049335 |
35 | GRK5 | 1.19871199 |
36 | TIE1 | 1.19473512 |
37 | PAK6 | 1.18214393 |
38 | TNIK | 1.17407406 |
39 | DMPK | 1.13397038 |
40 | FLT3 | 1.06639927 |
41 | ARAF | 1.04359941 |
42 | PRKCH | 1.01970855 |
43 | MAP3K7 | 1.01359050 |
44 | CDC42BPA | 1.01211457 |
45 | SGK494 | 1.00619099 |
46 | SGK223 | 1.00619099 |
47 | EPHB2 | 1.00534744 |
48 | TRPM7 | 0.98556592 |
49 | MAP2K6 | 0.98527780 |
50 | CAMKK1 | 0.98525238 |
51 | PDGFRA | 0.97209005 |
52 | ERN1 | 0.95072219 |
53 | BRAF | 0.93128662 |
54 | PTK2 | 0.92328435 |
55 | PRKD2 | 0.91187757 |
56 | TAOK3 | 0.91142908 |
57 | * CDK5 | 0.90190972 |
58 | MAP2K7 | 0.88688796 |
59 | PRKG1 | 0.88257656 |
60 | DAPK1 | 0.87337066 |
61 | PRKCG | 0.85729011 |
62 | STK11 | 0.85346230 |
63 | RIPK1 | 0.84814610 |
64 | STK16 | 0.81872952 |
65 | PKN1 | 0.80866560 |
66 | LIMK1 | 0.80781480 |
67 | NME1 | 0.78812250 |
68 | MAPK4 | 0.78533241 |
69 | NTRK2 | 0.78526530 |
70 | LATS2 | 0.77849870 |
71 | KSR1 | 0.76606920 |
72 | SGK2 | 0.76074048 |
73 | CAMK2B | 0.73414366 |
74 | PINK1 | 0.70949743 |
75 | WNK1 | 0.70655444 |
76 | MAPKAPK3 | 0.69757351 |
77 | TRIB3 | 0.69595028 |
78 | CAMK4 | 0.69114463 |
79 | MAPK13 | 0.68306721 |
80 | PRKCE | 0.68017059 |
81 | MAP2K4 | 0.67824373 |
82 | DYRK1A | 0.63146787 |
83 | CAMK2D | 0.62932258 |
84 | DYRK2 | 0.62300753 |
85 | FER | 0.62239278 |
86 | RET | 0.62085195 |
87 | AKT2 | 0.60959545 |
88 | MOS | 0.60469756 |
89 | ABL2 | 0.59684744 |
90 | PRPF4B | 0.59610015 |
91 | MAP3K11 | 0.59569537 |
92 | NLK | 0.58856223 |
93 | PRKAA1 | 0.56379276 |
94 | IRAK1 | 0.56362612 |
95 | MYLK | 0.56054512 |
96 | RIPK4 | 0.55509751 |
97 | MARK2 | 0.54878318 |
98 | PRKCI | 0.54333004 |
99 | SIK1 | 0.54019749 |
100 | DYRK1B | 0.53648651 |
101 | BMPR2 | 0.53352703 |
102 | STK38 | 0.53038920 |
103 | CAMK1G | 0.52643697 |
104 | CAMK2A | 0.52578563 |
105 | SGK1 | 0.51967275 |
106 | EPHA3 | 0.51753807 |
107 | PNCK | 0.51711686 |
108 | PDK2 | 0.51324218 |
109 | SGK3 | 0.50859959 |
110 | GRK1 | 0.48447129 |
111 | * RPS6KA3 | 0.48397264 |
112 | OBSCN | 0.48066798 |
113 | MET | 0.47791177 |
114 | MAP2K1 | 0.46267701 |
115 | MAP2K3 | 0.45473577 |
116 | PRKACB | 0.44422012 |
117 | PRKACG | 0.44239743 |
118 | CAMK1D | 0.44165840 |
119 | NEK1 | 0.44100260 |
120 | AKT3 | 0.44050397 |
121 | CDK14 | 0.43708410 |
122 | CSNK1A1 | 0.43354956 |
123 | BRSK1 | 0.43027453 |
124 | TESK1 | 0.42573816 |
125 | RPS6KA2 | 0.42192638 |
126 | MAP2K2 | 0.41280890 |
127 | ICK | 0.40593200 |
128 | * PRKACA | 0.40474201 |
129 | FGFR2 | 0.40398246 |
130 | ROCK1 | 0.39743188 |
131 | IRAK2 | 0.38786897 |
132 | EPHB1 | 0.37737132 |
133 | BCR | 0.37234068 |
134 | PIK3CA | 0.36860876 |
135 | PDPK1 | 0.33547855 |
136 | PRKD1 | 0.33411050 |
137 | PDK1 | 0.33063331 |
138 | PLK2 | 0.32648228 |
139 | PRKCZ | 0.32605914 |
140 | MAPK10 | 0.32066008 |
141 | LMTK2 | 0.30599565 |
142 | CSNK1G2 | 0.30589113 |
143 | ERBB3 | 0.30537765 |
144 | CDK18 | 0.30058907 |
145 | TAOK1 | 0.28802201 |
146 | ADRBK1 | 0.28776293 |
147 | CAMK2G | 0.28678810 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.36219737 |
2 | Insulin secretion_Homo sapiens_hsa04911 | 3.30136234 |
3 | Protein export_Homo sapiens_hsa03060 | 3.28734290 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.43972579 |
5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39812369 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32087441 |
7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30268460 |
8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23871863 |
9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22600853 |
10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.21913099 |
11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.16373321 |
12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.08839713 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01811040 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.97022511 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95033937 |
16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.93524517 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90554318 |
18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89043050 |
19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.87830277 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87407767 |
21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.86941608 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85873856 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85736210 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.85469974 |
25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.79950729 |
26 | Taste transduction_Homo sapiens_hsa04742 | 1.76341342 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73245496 |
28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72967414 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65168891 |
30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.62581537 |
31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61401427 |
32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.54603566 |
33 | * Long-term potentiation_Homo sapiens_hsa04720 | 1.52100961 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49714833 |
35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.48256065 |
36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47158872 |
37 | Morphine addiction_Homo sapiens_hsa05032 | 1.45422838 |
38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44009516 |
39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41290126 |
40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37849961 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37152073 |
42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37121349 |
43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35703923 |
44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28927191 |
45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28036153 |
46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.27455658 |
47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.23671496 |
48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23533987 |
49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23210777 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18205057 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16885263 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16723674 |
53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16251496 |
54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.16230146 |
55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15332329 |
56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13832912 |
57 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13315695 |
58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11457428 |
59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07331160 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06939254 |
61 | Renin secretion_Homo sapiens_hsa04924 | 1.05979512 |
62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.05290042 |
63 | Salivary secretion_Homo sapiens_hsa04970 | 1.03169934 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02711603 |
65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01702988 |
66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01647187 |
67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98975859 |
68 | Peroxisome_Homo sapiens_hsa04146 | 0.97516639 |
69 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95593281 |
70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95586728 |
71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95223483 |
72 | Lysosome_Homo sapiens_hsa04142 | 0.93244295 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87825653 |
74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87714149 |
75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86226540 |
76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85116386 |
77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81540347 |
78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79251550 |
79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78342603 |
80 | Long-term depression_Homo sapiens_hsa04730 | 0.77430122 |
81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76188772 |
82 | Gap junction_Homo sapiens_hsa04540 | 0.73681462 |
83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73440597 |
84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73136425 |
85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70448945 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69595130 |
87 | Insulin resistance_Homo sapiens_hsa04931 | 0.67603666 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67372732 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67049573 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66959549 |
91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66827050 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66268198 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64260049 |
94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62840636 |
95 | Alcoholism_Homo sapiens_hsa05034 | 0.62565264 |
96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62448509 |
97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62123604 |
98 | Melanogenesis_Homo sapiens_hsa04916 | 0.62108027 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61907536 |
100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61499533 |
101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60985812 |
102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60022829 |
103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59513759 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.57493679 |
105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56712097 |
106 | Phototransduction_Homo sapiens_hsa04744 | 0.56608005 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56009646 |
108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53577246 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53530508 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52789247 |
111 | Glioma_Homo sapiens_hsa05214 | 0.50724858 |
112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50607596 |
113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49433772 |
114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47183114 |
115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44858672 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44102886 |
117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43944462 |
118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42480608 |
119 | Bile secretion_Homo sapiens_hsa04976 | 0.41585463 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41517871 |
121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39642864 |
122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39084158 |
123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38701891 |
124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38321223 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38268374 |
126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38185191 |
127 | Tight junction_Homo sapiens_hsa04530 | 0.37454854 |
128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37205561 |
129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37170389 |
130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33634020 |
131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.32094323 |
132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31716105 |
133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31650728 |
134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30621087 |
135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30585716 |
136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30029401 |
137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27877929 |
138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27760434 |
139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27607566 |
140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27503023 |
141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25461310 |
142 | Mineral absorption_Homo sapiens_hsa04978 | 0.25261444 |
143 | ABC transporters_Homo sapiens_hsa02010 | 0.24885172 |
144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23721708 |